MFDS — authorised 8 December 1999
- Marketing authorisation holder: LIEBEL-FLARSHEIM
- Status: likely_approved
🇰🇷 Optimark in South Korea
MFDS authorised Optimark on 8 December 1999
Marketing authorisation
Optimark in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Optimark approved in South Korea?
Yes. MFDS authorised it on 8 December 1999.
Who is the marketing authorisation holder for Optimark in South Korea?
LIEBEL-FLARSHEIM holds the South Korean marketing authorisation.